Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002170:Canada; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D004196:Disease Outbreaks / Q000517:prevention & control; D005260:Female; D006282:Health Personnel; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype; D053122:Influenza A Virus, H3N2 Subtype; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D005585:Influenza in Birds / Q000453:epidemiology; D007251:Influenza, Human / Q000517:prevention & control*; D008875:Middle Aged; D053139:Oseltamivir / Q000008:administration & dosage / Q000627:therapeutic use; D011200:Poultry / Q000821:virology; D011247:Pregnancy
D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir